Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunization Against COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04651790
What this trial is testing

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults

Who this might be right for
Covid19Vaccines
Pontificia Universidad Catolica de Chile 2,300
Large-scale testing (Phase 3)UnknownNCT05580159
What this trial is testing

New Generation mRNA Booster Vaccine Against Emerging VOCs

Who this might be right for
ImmunogenicityEfficacySafety
Stemirna Therapeutics 2,000
Not applicableUnknownNCT04836793
What this trial is testing

COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2

Who this might be right for
CancerElderlyHealthy Aging
Centre Hospitalier Universitaire de Besancon 300
Not applicableUnknownNCT04832932
What this trial is testing

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Who this might be right for
COVID-19 Vaccines
Mebo Research, Inc. 2,000
Not applicableStudy completedNCT05124223
What this trial is testing

Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19

Who this might be right for
Myocarditis Acute
Sebastian Kelle 131
Not applicableStudy completedNCT05589233
What this trial is testing

COVID-19 Vaccination AZV 2021-2023

Who this might be right for
COVID-19VaccinationImmunity+1 more
University Hospital Hradec Kralove 3,000
Post-approval studies (Phase 4)Ended earlyNCT05075538
What this trial is testing

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

Who this might be right for
Cancer
Jules Bordet Institute 152
Not applicableUnknownNCT04746092
What this trial is testing

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

Who this might be right for
CLLMultiple MyelomaLymphoma
Tel-Aviv Sourasky Medical Center 630
Large-scale testing (Phase 3)Study completedNCT05246137
What this trial is testing

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 2,646
Not applicableStudy completedNCT04832022
What this trial is testing

Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination

Who this might be right for
Rheumatic DiseasesSARS-CoV InfectionCOVID-19
University Hospital, Montpellier 397
Not applicableLooking for participantsNCT06168032
What this trial is testing

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

Who this might be right for
COVID-19 RecurrentLung CancerVaccination+3 more
Peking Union Medical College Hospital 1,224
Early research (Phase 1)WithdrawnNCT05430958
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

Who this might be right for
Coronavirus Infection
Inovio Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT05602961
What this trial is testing

A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster

Who this might be right for
COVID-19
GreenLight Biosciences, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04788459
What this trial is testing

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Who this might be right for
COVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation
Takis 68
Not applicableUnknownNCT04347694
What this trial is testing

Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.

Who this might be right for
SARS-CoV 2Immunization; Infection
Medical University of Vienna 400
Post-approval studies (Phase 4)Active Not RecruitingNCT07279766
What this trial is testing

Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19

Who this might be right for
COVID-19
Tor Biering-Sørensen 285,000
Very early researchStudy completedNCT05655351
What this trial is testing

Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.

Who this might be right for
CORONAVIRUS INFECTIONS
Centre Hospitalier Universitaire de Nīmes 30
Not applicableUnknownNCT05153850
What this trial is testing

Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2

Who this might be right for
COVID-19
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 243
Large-scale testing (Phase 3)Study completedNCT05710783
What this trial is testing

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

Who this might be right for
SARS-CoV-2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 4,065
Post-approval studies (Phase 4)Study completedNCT06020118
What this trial is testing

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

Who this might be right for
InfluenzaCOVID-19
Duke University 455
Next Page